8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements

Gilead ($GILD) announced Q4 & FY 2025 results on Feb 10, 2026; press release is filed as Exhibit 99.1 to…

Filed with the SEC on · Summarized by InvestorsBot

Gilead ($GILD) announced Q4 & FY 2025 results on Feb 10, 2026; press release is filed as Exhibit 99.1 to the 8‑K — see Exhibit 99.1 for full financial details. 📢📄 #Earnings #SECfilings

Gilead ($GILD) presented both GAAP and non‑GAAP metrics; management uses non‑GAAP for operating/budget planning. Reconciliations of GAAP to non‑GAAP are on pages 11–14 of the press release. ⚖️ #Biotech #Earnings

Gilead ($GILD) notes Item 2.02/9.01 and Exhibit 99.1 are “furnished,” not “filed” under Section 18 — not subject to Section 18 liabilities and not incorporated by reference in other filings. 📝 #SECfilings #Compliance

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from GILEAD SCIENCES, INC.